Bisphenol derivatives and their use as androgen receptor activity modulators
US11142508B2 · kind B2 · utility
4Cited by
29References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 14, 2020 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Apr 14, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having a structure of Formula I or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, and X, are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.